IP Library › Granted Patent US 12,256,765
Granted Patent B2
US 12,256,765 · App. 17/021,339 · Granted Mar 25, 2025

Hydrolyzed pea protein-based nutrient composition

Inventors: Richard Craig Laver (Park City, UT); Michelle Irene Laver (Park City, UT); Brett Holbrook Matthews (Santa Barbara, CA); William Bernard Pickar (Napa, CA); David Arthur Cole (Peoria, AZ); Steven Anthony Witherly (Valencia, CA); Caroline Hsin-Ai Witherly (Valencia, CA); Vanessa Laura Millovich (Carpinteria, CA); Christina Guerra Phreaner (Santa Barbara, CA)
Assignee: Kate Farms, Inc.
A23L33/18A23L33/105A23L33/12A23L33/15A23L33/16A23L33/185A23L33/21A61K9/0019A61K31/01A61K31/015A61K31/198A61K31/216A61K31/23A61K31/255A61K31/353A61K31/375A61K31/7028A61K31/733A61K33/00A61K33/06A61K33/14A61K36/21A61K36/28A61K36/53A61K36/537A61K36/55A61K38/168A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,256,765
App. No.
17/021,339
Granted
Mar 25, 2025
Kind
B2
Abstract

The present invention discloses a nutritional composition and method of using and making the nutritional composition. The nutritional composition is a hydrolyzed pea protein based nutrient composition for use in both enteral and oral feeding, and provides a non-allergenic diet for providing optimal nutrition to users. The nutritional composition is made from organic and plant-based ingredients. The nutritional composition has pea protein hydrolysates, phytochemical extracts, fatty acids, organic ingredients free of the top eight allergens and corn, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and/or oral feeding.

Claims (50)

1. A method for making an organic nutrition composition, comprising:

(a) forming a pea protein slurry by mixing organic hydrolyzed pea protein with water, wherein the organic hydrolyzed pea protein is about 100 wt % pea protein hydrolysate based on total protein of the mixture;

(b) forming a protein-fat slurry by mixing fat with the pea protein slurry, wherein the fat has a weight ratio of omega 6 to omega 3 in the range of between 3:1 and 4:1, and wherein the fat comprises organic high linoleic sunflower oil;

(c) mixing dry ingredients with the protein-fat slurry;

(d) mixing organic agave syrup with a mixture of step (c); and

(e) producing the organic nutrition composition aseptically through a processor.

2. The method of claim 1 , wherein the mixing of the organic hydrolyzed pea protein in the water is performed for ten minutes.

3. The method of claim 1 , wherein the mixing of the fat with the pea protein slurry is performed for five minutes.

4. The method of claim 1 , wherein the mixing of the dry ingredients with the protein-fat slurry is performed for five minutes.

5. The method of claim 1 , wherein the mixing of the organic agave syrup with the mixture of (c) is performed for ten minutes.

6. The method of claim 1 , further comprising: performing Ultra High Temperature treatment of the organic nutrition composition.

7. The method of claim 1 , further comprising: passing flat, unformed packaging material through a heated hydrogen peroxide bath; and filling the organic nutrition composition into the packaging material.

8. The method of claim 7 , wherein the hydrogen peroxide concentration of the bath is 30%, and wherein the bath is heated to at least 70° C.

9. The method of claim 7 , further comprising: eliminating the hydrogen peroxide from the packaging material using pressure rollers or hot air.

10. The method of claim 1 , further comprising forming the protein-fat slurry by mixing additional fat with the pea protein slurry, wherein the additional fat has a weight ratio of organic medium chain triglycerides to long-chain triglycerides in the range of 40:60 to 50:50.

11. The method of claim 1 , wherein the organic nutrition composition comprises from 6 wt % to 9.2 wt % of the organic hydrolyzed pea protein.

12. The method of claim 10 , wherein a maximum concentration of the organic medium chain triglycerides is 2.8 wt % of the organic nutrition composition.

13. The method of claim 10 , wherein a minimum concentration of the organic medium chain triglycerides is 2.3 wt % of the total organic nutrition composition.

14. The method of claim 10 , wherein a concentration of the organic medium chain triglycerides is 2.74 wt % of the organic nutrition composition.

15. The method of claim 1 , wherein the protein-fat slurry is free of allergens.

16. The method of claim 15 , wherein the protein-fat slurry is free of the following allergens: milk, wheat, soybeans, eggs, peanuts, tree nuts, fish, shellfish and corn.

17. The method of claim 1 , wherein a minimum concentration of the organic agave syrup is 2.25 wt % of the organic nutrition composition.

18. The method of claim 1 , wherein a maximum concentration of the organic agave syrup is 6.5 wt % of the organic nutrition composition.

19. The method of claim 1 , further comprising mixing organic brown rice syrup solids with a mixture of step (d) prior to step (e).

20. The method of claim 19 , wherein a minimum concentration of the organic brown rice syrup solids is 6.5 wt % of the organic nutrition composition.

21. The method of claim 19 , wherein a maximum concentration of the organic brown rice syrup solids is 10 wt % of the organic nutrition composition.

22. The method of claim 1 , wherein a maximum concentration of the organic high linoleic sunflower oil is 3.5 wt % of the organic nutrition composition.

23. The method of claim 1 , wherein a minimum concentration of the organic high linoleic sunflower oil is 2.5 wt % of the organic nutrition composition.

24. The method of claim 1 , wherein the fat further comprises organic flaxseed oil.

25. The method of claim 24 , wherein a maximum concentration of the organic flaxseed oil is 1.5 wt % of the organic nutrition composition.

26. The method of claim 24 , wherein a minimum concentration of the organic flaxseed oil is 1.1 wt % of the organic nutrition composition.

27. The method of claim 1 , wherein the dry ingredients comprise organic rosemary extract.

28. The method of claim 27 , wherein the organic rosemary extract is 0.03 wt % to 0.05 wt % of the organic nutrition composition.

29. The method of claim 27 , wherein the dry ingredients further comprise potassium citrate, sodium ascorbate, prebiotic fibers, organic sunflower lecithin, or starch.

30. The method of claim 29 , wherein the prebiotic fibers comprise organic agave inulin.

31. The method of claim 30 , wherein a maximum concentration of the organic agave inulin is 1.2 wt % of the organic nutrition composition.

32. The method of claim 30 , wherein a minimum concentration of the organic agave inulin is 1.0 wt % of the organic nutrition composition.

33. The method of claim 7 , further comprising: sterilizing the packaging material prior to filling the packaging material with the organic nutrition composition.

34. The method of claim 1 , wherein the water is purified water.

35. The method of claim 1 , wherein the organic nutrition composition is formulated in a liquid form.

36. The method of claim 1 , wherein the organic nutrition composition is formulated for enteral or oral feeding.

37. The method of claim 1 , wherein the organic hydrolyzed pea protein is provided in an amount within a range of from 6 wt % to 9.2 wt % based on the organic nutrition composition, the organic agave syrup is provided in an amount within a range of from 2.25 wt % to 6.5 wt % based on the organic nutrition composition, and the organic high linoleic sunflower oil is provided in an amount within a range of from 2.5 wt % to 3.5 wt % based on the organic nutrition composition.

38. The method of claim 37 , wherein the organic hydrolyzed pea protein is provided in an amount within a range of from 6 wt % to 9.2 wt % based on the organic nutrition composition, the organic agave syrup is provided in an amount within a range of from 2.25 wt % to 6.5 wt % based on the organic nutrition composition, the organic high linoleic sunflower oil is provided in an amount within a range of from 2.5 wt % to 3.5 wt % based on the organic nutrition composition, and wherein the fat further comprises organic flaxseed oil provided in an amount within a range of from 1.1 wt % to 1.5 wt % based on the organic nutrition composition.

39. A method for making an organic nutrition composition, comprising:

(a) forming a pea protein slurry by mixing organic hydrolyzed pea protein with water;

(b) forming a protein-fat slurry by mixing fat with the pea protein slurry, wherein the fat comprises organic high linoleic sunflower oil, and wherein the fat has a weight ratio of omega 6 to omega 3 in the range of between 3:1 and 4:1;

(c) mixing dry ingredients with the protein-fat slurry, wherein the dry ingredients comprise organic rosemary extract;

(d) mixing organic agave syrup with a mixture of step (c);

(e) mixing organic brown rice syrup solids with a mixture of step (d); and

(f) producing the organic nutrition composition aseptically through a processor, wherein the organic nutrition composition comprises: (i) 6 wt % to 9.2 wt % of the organic hydrolyzed pea protein, (ii) 2.5 wt % to 3.5 wt % of the organic high linoleic sunflower oil, (iii) 2.25 wt % to 6.5 wt % of the organic agave syrup, and (iv) 6.5 wt % to 10 wt % of the organic brown rice syrup solids.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jul 1, 2025
From: BANC OF CALIFORNIA (FORMERLY KNOWN AS PACIFIC WESTERN BANK)
To: KATE FARMS, INC.
Reel/Frame 071583/0713 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2025
From: LAVER, RICHARD; LAVER, MICHELLE; WITHERLY, STEVEN
To: KATE FARMS, INC.
Reel/Frame 070225/0118 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2025
From: MATTHEWS, BRETT HOLBROOK; PICKAR, WILLIAM BERNARD; PHREANER, CHRISTINA GUERRA; COLE, DAVID ARTHUR; WITHERLY, CAROLINE HSIN-AI; MILLOVICH, VANESSA LAURA
To: KATE FARMS, INC.
Reel/Frame 070225/0161 →
SECURITY INTEREST Recorded Nov 5, 2024
From: KATE FARMS, INC.
To: BANC OF CALIFORNIA (FORMERLY KNOWN AS PACIFIC WESTERN BANK)
Reel/Frame 069146/0972 →
SECURITY INTEREST Recorded May 12, 2021
From: KATE FARMS, INC.
To: PACIFIC WESTERN BANK
Reel/Frame 056220/0096 →
Continuity (2)
Division 15980355 · May 15, 2018
Related Publication 20210045423A1 · Feb 18, 2021
References Cited (146)
US 5424034A · Hilmersson · 1995 [cited by examiner]
US 5629023A · Bland · 1997 [cited by examiner]
US 5728678A · Trimbo · 1998 [cited by examiner]
US 6277092B1 · Cole et al. · 2001 [cited by applicant]
US 6989161B2 · Roufs et al. · 2006 [cited by applicant]
US 7875291B1 · Habib et al. · 2011 [cited by applicant]
US 9687012B2 · Kesler et al. · 2017 [cited by applicant]
US 9801814B2 · Mager et al. · 2017 [cited by applicant]
US 10806169B2 · Laver et al. · 2020 [cited by applicant]
US 20030104033A1 · Lai et al. · 2003 [cited by applicant]
US 20070014909A1 · Mai et al. · 2007 [cited by applicant]
US 20070042992A1 · Frippiat et al. · 2007 [cited by applicant]
US 20070148305A1 · Sherwood et al. · 2007 [cited by applicant]
US 20070224323A1 · Goldman · 2007 [cited by applicant]
US 20090087519A1 · Hundscheid et al. · 2009 [cited by applicant]
US 20090124685A1 · Uribe et al. · 2009 [cited by applicant]
US 20090304823A1 · Offord Cavin et al. · 2009 [cited by applicant]
US 20100124592A1 · Anderson · 2010 [cited by examiner]
US 20100184963A1 · Scanlin et al. · 2010 [cited by applicant]
US 20100239712A1 · Brooks et al. · 2010 [cited by applicant]
US 20110021421A1 · Kiers et al. · 2011 [cited by applicant]
US 20110206787A1 · West et al. · 2011 [cited by applicant]
US 20110257089A1 · Huisman et al. · 2011 [cited by applicant]
US 20120040014A1 · Settineri · 2012 [cited by examiner]
US 20120100257A1 · Lambach et al. · 2012 [cited by applicant]
US 20130023468A1 · Hofman et al. · 2013 [cited by applicant]
US 20130115329A1 · Savant et al. · 2013 [cited by applicant]
US 20130203663A1 · Mager et al. · 2013 [cited by applicant]
US 20130210715A1 · Greenberg et al. · 2013 [cited by applicant]
US 20130243904A1 · Cordle · 2013 [cited by examiner]
US 20130261183A1 · Bhagat · 2013 [cited by applicant]
US 20140113031A1 · Lee · 2014 [cited by applicant]
US 20140154364A1 · Cotton et al. · 2014 [cited by applicant]
US 20140335252A1 · Arcieri · 2014 [cited by applicant]
US 20150164985A1 · Van Den Braak et al. · 2015 [cited by applicant]
US 20150305359A1 · Ao · 2015 [cited by examiner]
US 20150342237A1 · Daikeler et al. · 2015 [cited by applicant]
US 20160113987A1 · Choi et al. · 2016 [cited by applicant]
US 20160278415A1 · Marsland · 2016 [cited by applicant]
US 20160316810A1 · Terp et al. · 2016 [cited by applicant]
US 20180015032A1 · LeBrun-Blashka et al. · 2018 [cited by applicant]
US 20190021387A1 · Barata et al. · 2019 [cited by applicant]
US 20190374569A1 · Laver et al. · 2019 [cited by applicant]
US 20200077691A1 · Dewille et al. · 2020 [cited by applicant]
US 20210401021A1 · Laver · 2021 [cited by examiner]
US 20220030909A1 · Laver et al. · 2022 [cited by applicant]
US 20230132388A9 · Laver et al. · 2023 [cited by applicant]
AU 2007340638B2 · 2010 [cited by examiner]
AU 2017225011 · 2017 [cited by applicant]
CN 1400869A · 2003 [cited by applicant]
CN 101175408A · 2008 [cited by applicant]
CN 102271525A · 2011 [cited by applicant]
CN 103025178A · 2013 [cited by applicant]
CN 103153095A · 2013 [cited by applicant]
CN 104322639A · 2015 [cited by applicant]
CN 105285023 · 2016 [cited by applicant]
CN 105533720 · 2016 [cited by applicant]
CN 105960173A · 2016 [cited by applicant]
CN 106962598A · 2017 [cited by applicant]
CN 107259586 · 2017 [cited by applicant]
CN 107684561 · 2018 [cited by applicant]
CN 107692221 · 2018 [cited by applicant]
CN 107997173 · 2018 [cited by applicant]
EP 2880996A1 · 2015 [cited by applicant]
EP 1972346 · 2015 [cited by applicant]
JP 3193095 · 2001 [cited by applicant]
JP 2008206479 · 2008 [cited by applicant]
JP 2014505702A · 2014 [cited by applicant]
JP 2017531429A · 2017 [cited by applicant]
JP 2021524755A · 2021 [cited by applicant]
WO WO2007063142 · 2007 [cited by applicant]
WO WO2010126362A1 · 2010 [cited by applicant]
WO WO2012027287 · 2012 [cited by applicant]
WO WO2013138906 · 2013 [cited by applicant]
WO WO2013148685 · 2013 [cited by applicant]
WO WO2017095897 · 2017 [cited by applicant]
WO WO2017129921A1 · 2017 [cited by applicant]
WO WO2019075307A1 · 2019 [cited by examiner]
WO WO2019222000A1 · 2019 [cited by applicant]
WO WO2019240943A1 · 2019 [cited by applicant]
Andrea et al., “Fruit Syrups: Sweet Concentrated Sources” The World of Food Ingredients, Mar. 2016, pp. 44-46 (Year: 2016). [cited by examiner]
International Preliminary Report on Patentability, mailed on Dec. 24, 2020, from International Application No. PCT/US19/034236, filed on May 29, 2019. 9 pages. [cited by applicant]
International Preliminary Report on Patentability, mailed on Nov. 26, 2020, from International Application No. PCT/US2019/031362, filed on May 8, 2019. 9 pages. [cited by applicant]
Anonymous, “Agave Inulin: All You Need to Know,” 1-4 (2016). [cited by applicant]
Calder, P. C., “Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?,” British Journal of Clinical Pharmacology, 75(3): 645-662 (2012). [cited by applicant]
Clinical Trial NCT01298154: Effects of Intact and Hydrolyzed Pea Protein on Food Intake, Glycemic Response and Subjective Appetite http://sunrisechildrenshospital.com/hi/?/21527/Branched-Chain-Amino-Acids-BCAAs-. [cited by applicant]
Gunnars, K., “How to Optimize Your Omega-6 to Omega-3 Ratio,” Jun. 11, 2018 (Jun. 11, 2018); p. 7-9, Section Entitled “Avoid Vegetable Oils High In Omega-6.” https://www.healthline.com/nutrition/optimize-omega-6-omega-3… [cited by applicant]
Holscher, H.D., “Dietary Fiber and Prebiotics and the Gastrointestinal Microbiota,” Gut Microbes, 8(2): 172-184 (2017). [cited by applicant]
Holsher, H.D., et al., “Agave Inulin Supplementation Affects the Fecal Microbiota of Healthy Adults Participating in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial 1-3,” The Journal of Nutrition, 145(9)… [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority, mailed on Sep. 11, 2019, from International Application No. PCT/US19/31362, filed on May 8, 2019. 11 pages. [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority, mailed on Sep. 17, 2019, from International Application No. PCT/US19/34236, filed on May 29, 2019. 10 pages. [cited by applicant]
Johnson, J.J., “Carnosol: A Promising Anti-Cancer and Anti-Inflammatory Agent,” Cancer Letters, 305(1): 1-7 (2011). [cited by applicant]
Mager, D.R., et al., “Branched chain amino acid requirements in School-Aged children determined by indicator Amino acid oxidation (IAAO),” J. Nutr., 133(11): 3540-3545 (2003). [cited by applicant]
Maroon, J.C., et al., “Ω-3 Fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain,” Surgical Neurology, 65(4): 326-331 (2006). [cited by applicant]
Nemzer, B.V., et al., New Insights on Effects of a Dietary Supplement on Oxidative and Nitrosative Stress on Humans, Food Science & Nutrition, 2(6): 828-839 (2014). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256589. [cited by applicant]
Nicolson, L.J., “Acute pancreatitis: should we use antibiotics?,” Curr. Gastroenterol. Rep., 13 (4): 336-343 (2011). [cited by applicant]
NSA, “Sunflower Oil” National Sunflower Association, Oct. 8, 2010 (Oct. 8, 2010); entire document. https://web.archive.org/web/20101008154453/https://www.sunflowernsa.com /oil/Linoleic-Sunflower-Oil/. [cited by applicant]
Overdiun, J., et al. . NUTRALYS® pea protein: characterization of in vitro gastric digestion and in vivo gastrointestinal peptide responses relevant to satiety, Food & Nutrition Research, 59: 25622 (2015). [cited by applicant]
Phillips, E.M., et al., “Peptide-Based Formulas: The Nutraceuticals of Enteral Feeding?,” EPCN, 40-45: (2005). [cited by applicant]
Shyamala, B, N., et al. “Studies on the Antioxidant Activities of Natural Vanilla Extract and Its Constituent Compounds through in Vitro Models,” Journal of Agric. Food Chem., 55 (19): 7738-7743 (2007). [cited by applicant]
Textron, “Sunflower Oil, Organic” Textran Product Data Sheet, Dec. 31, 2007 (Dec. 31, 2007); p. 1. https://www.brenntag.com/media/documents/bsi/product_data_sheets/life_science/textron_natural_oils/sunflower_oil_refined… [cited by applicant]
Wikipedia, “Dietary fiber”, Nov. 30, 2017 (Nov. 30, 2017), retrieved on Jul. 8, 2019 from 1-19 https://en.wikipedia.org/w/index.php?title=Dietary_fiber&oldid=812822101; entire document, especially p. 6 para 4. [cited by applicant]
Muanda, F., et al. “Phytochemical Composition and Antioxidant Capacity of Three Malian Medicinal Plant Parts,” Evidence-Based Complementary and Alternative Medicine, 2011, Article ID 674320, 1-8 (2008). [cited by applicant]
Anonymous, “PURE. Manufacturer of Hypoallergenic Nutritional Supplements,” URL:https://www.pureencapsulationspro.com/media/PLs/2017 PL_ Catalog_Price_web.pdf (2017). [cited by applicant]
Supplementary European Search Report, mailed on Jan. 13, 2022, from European Patent Application No. 19 80 4397, filed on May 8, 2019. 3 pages. [cited by applicant]
Supplementary European Search Report, completed on Jan. 12, 2022, from European Patent Application No. 19 81 9010, filed on May 29, 2019. 2 pages. [cited by applicant]
Aluko, R.E., “Determination of Nutritional and Bioactive Properties of Peptides in Enzymatic Pea, Chickpea, and Mung Bean Protein Hydrolysates,” [cited by applicant]
Boehm, A. et al., “Heat-induced degradation of inulin,” [cited by applicant]
Chakrabarti, S. et al., “Bioactive peptides on endothelial function,” [cited by applicant]
Chakrabarti, S. et al., “Food-Derived Bioactive Peptides on Inflammation and Oxidative Stress,” [cited by applicant]
Chalamaiah, M. et al., “Immunomodulatory and anticancer protein hydrolysates (peptides) from food proteins: A review,” [cited by applicant]
Corrochano, A.R. et al., “Intestinal health benefits of bovine whey proteins after simulated gastrointestinal digestion,” [cited by applicant]
Corrochano, A.R. et al., “Invited review: Whey proteins as antioxidants and promoters of cellular antioxidant pathways,” [cited by applicant]
Feng, J. et al., “Maillard reaction products as functional components in oil-in-water emulsions: A review highlighting interfacial and antioxidant properties,” [cited by applicant]
Gilmartin, S. et al., “Whey for Sarcopenia; Can Whey Peptides, Hydrolysates or Proteins Play a Beneficial Role?,” [cited by applicant]
Girgih, A.T. et al., “Preventive and treatment effects of a hemp seed ( [cited by applicant]
Jiang, W. et al., “Impact of pea protein-inulin conjugates prepared via the Maillard reaction using a combination of ultrasound and pH-shift treatments on physical and oxidative stability of algae oil emulsions,” [cited by applicant]
Kutzli, I. et al., “Glycation of Plant Proteins via Maillard Reaction: Reaction Chemistry, Technofunctional Properties, and Potential Food Application,” [cited by applicant]
Li, H. et al., “Blood Pressure Lowering Effect of a Pea Protein Hydrolysate in Hypertensive Rats and Humans,” [cited by applicant]
Li, S. et al., “Molecular targets and mechanisms of bioactive peptides against metabolic syndromes,” [cited by applicant]
Luna-Vital, D. et al., “Peptides from legumes with antigastrointestinal cancer potential: current evidence for their molecular mechanisms,” Accepted Manuscript, [cited by applicant]
Malomo, S.A. et al., “Structural and Antihypertensive Properties of Enzymatic Hemp Seed Protein Hydrolysates,” [cited by applicant]
Mancilla-Margalli, N.A. et al., “Generation of Maillard Compounds from Inulin during the Thermal Processing of [cited by applicant]
Martínez-Maqueda, D et al., “Antihypertensive peptides from food proteins: a review,” [cited by applicant]
Mojica, L. et al., “Evaluation of the hypoglycemic potential of a black bean hydrolyzed protein isolate and its pure peptides using in silico, in vitro and in vivo approaches,” [cited by applicant]
Mojica, L. et al., “Optimization of enzymatic production of anti-diabetic peptides from black bean ( [cited by applicant]
Real Hernandez, L.M. et al., “Enzymatic Production, Bioactivity, and Bitterness of Chickpea ( [cited by applicant]
Shaw, K.A., et al., “The Feasibility of a Pea Protein Supplement with High Iron Bioavailability for Female Runners: A Randomized Control Trial,” [cited by applicant]
Udenigwe, C.C. et al., “Food Protein-Derived Bioactive Peptides: Production, Processing, and Potential Health Benefits,” [cited by applicant]
Vermeirssen, V. et al., “Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides,” [cited by applicant]
Xu, Q. et al., “Bioavailability of bioactive peptides derived from food proteins across the intestinal epithelial membrane: A review,” [cited by applicant]
Zha, F. et al., “Conjugation of Pea Protein Isolate via Maillard-Driven Chemistry with Saccharide of Diverse Molecular Mass: Molecular Interactions Leading to Aggregation or Glycation, ” [cited by applicant]
Zhang, Z. et al., “Maillard reaction between pea protein isolate and maltodextrin via wet-heating route for emulsion stabilisation,” [cited by applicant]
Moore, C., “Kate Farms Launches Core Essentials Peptide Tube Feeding Formula for CF, Other Conditions”, Cystic Fibrosis News Today, Aug. 15, 2017, pp. 6. [cited by applicant]
Nemzer, B.V., et al., “New insights on effects of a dietary supplement on oxidative and nitrosative stress in humans”, Food Science & Nutrition, 2(6), 828-839, (2014). [cited by applicant]
Bailey, M. et al., “Weight Gain in Oncology Patients Using a Plant-Based Oral Nutrition Supplement,” Clinical Nutrition ESPEN, 40:661 (2020). [cited by applicant]
Cohen, S. et al., “Improved GI Tolerance and Weight Gain in Pediatric Patients Using Plant-Based Enteral Formulas,” Journal of Parenteral and Enteral Nutrition, 44(3): 274 (2020). [cited by applicant]
Cohen, S. et al., “Patient-Reported Outcomes Indicate Plant-Based Enteral Formula Improves Nutrition and Gastrointestinal Symptoms,” Journal of Parenteral and Enteral Nutrition, 44 (3): 275 (2020). [cited by applicant]
Cohen, S. et al., “Patient-Reported Outcomes of GI Symptoms and Adherence Among Pediatric Patients Using a Pea Protein Plant-Based Enteral Formula,” JPGN, S454-456 (2020). [cited by applicant]
Kate Farms Komplete Vanilla Meal Replacement Shake, Gluten Free, NutFree, Dairy Free, Organic Plant Protein Ready to Drink Case of 12, amazon.sg, Mar. 1, 2017 (online), pp. 1-6 and retrieved on Sep. 29, 2023, retrieved … [cited by applicant]
Anonymous, “Frequently Asked Questions About Medical Foods; Second Edition,” U. S. Department of Health and Human Services, 1-12 (2016). [cited by applicant]
Anonymous: “Vanilla Bliss Meal Replacement Shake”, MINTEL; Jun. 17, 2014. 4 Pages. [cited by applicant]
Julson, E., “Pea Protein Powder: Nutrition, Benefits and Side Effects”, Nov. 30, 2018, downloaded on Mar. 23, 2023 from https://web.archive.org/web/20181130212649/www.healthline.com/nutrition/pea-protein-powder (Julson)… [cited by applicant]
Kate Farms Shakes: Komplete, Peptide 1.0 and Peptide 1.5. Vegan and Hypoallergenic Complete Nutrition Meal Replacement Protein Shakes (Corn free, Soy free, Wheat free, Dairy free)., Jan. 11, 2017(online), pp. 1-6, retri… [cited by applicant]
Nemzer, B., et al., “Decrease of Free Radical Concentrations in Humans Following Consumption of a High Antioxidant Capacity Natural Product,” Food Science & Nutrition, 2(6): 647-654 (2014). [cited by applicant]
Pure Encapsulations, ‘Manufacturer of Hypoallergenic Nutritional Supplements. 2017 Professional Product List’, [retrieved from the Internet Feb. 6, 2024] URL:https://www.pureencapsulationspro.com/media/PLs/2017_PL_Catal… [cited by applicant]